In a recent study, we reported that co-vaccination with a chemokine, mouse RANTES (mRANTES) and a tumor-specific antigen gene, human gp100 (hgp100) within a specific time frame can induce a strong cell-mediated immunity against targeted B16/hgp100-tumor cells [20]. Here, CCL5 is linked to neoplasm.